Charles Theuer - Net Worth and Insider Trading
Charles Theuer Net Worth
The estimated net worth of Charles Theuer is at least $835 dollars as of 2024-11-05. Charles Theuer is the President and CEO of TRACON Pharmaceuticals Inc and owns about 19,971 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $835. Details can be seen in Charles Theuer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Theuer has not made any transactions after 2023-04-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Theuer
Charles Theuer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Theuer owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , Oncternal Therapeutics Inc (ONCT) , and 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of Charles Theuer’s form 4 insider trades.
Insider Ownership Summary of Charles Theuer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2023-04-27 | director & President and CEO |
| ONCT | Oncternal Therapeutics Inc | 2019-06-07 | director |
| FDMT | 4D Molecular Therapeutics Inc | 2020-12-10 | director |
Charles Theuer Latest Holdings Summary
Charles Theuer currently owns a total of 1 stock. Charles Theuer owns 19,971 shares of TRACON Pharmaceuticals Inc (TCON) as of April 27, 2023, with a value of $835.
Latest Holdings of Charles Theuer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2023-04-27 | 19,971 | 0.04 | 835 |
Holding Weightings of Charles Theuer
Charles Theuer Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Theuer has made a total of 36 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 36 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 2,550 shares on April 27, 2023, which cost Charles Theuer around $37,739.
Insider Trading History of Charles Theuer
- 1
Charles Theuer Trading Performance
GuruFocus tracks the stock performance after each of Charles Theuer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Theuer is 54%. GuruFocus also compares Charles Theuer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Theuer within 3 months outperforms 17 times out of 38 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Theuer's insider trading performs compared to the benchmark.
Performance of Charles Theuer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.94 | | | | | |
| Relative Return to S&P 500(%) | 29.68 | | | | | |
Charles Theuer Ownership Network
Ownership Network List of Charles Theuer
Ownership Network Relation of Charles Theuer
Charles Theuer Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Charles Theuer is the director & President and CEO of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , Chief Operating Officer Bonne J. Adams , and Chief Accounting Officer (PAO) Scott B. Brown .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Charles Theuer made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Charles Theuer Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Theuer. You might contact Charles Theuer via mailing address: C/o Tracon Pharmaceuticals, Inc., 4350 La Jolla Village Drive, Suite 800, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
